Archives
|
Entry
|
Blogger
|
Date
▴
|
Xconomist
|
Location
|
|
Xconomy Closes Second Financing Round
|
Robert Buderi |
11/25/08 |
|
National
|
|
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/20/08 |
|
Boston
|
|
Brightcove Bonds with Conde Nast, BSX Backs Brain-Implant Firm, $8 Million Shared With PeerApp, & More Boston-Area Deals News
|
Rebecca Zacks |
11/18/08 |
|
Boston
|
|
ZafGen Scores $14M Series B
|
Rebecca Zacks |
11/17/08 |
|
Boston
|
|
Zafgen, Inc. Lands $14,000,000 Series B Financing Round
|
VentureDeal |
11/17/08 |
|
Boston
|
|
Genzyme and Osiris Forge Stem-Cell Agreement, Xtalic Nabs $10M for Nano Alloys, Atlas Out for Half a Billion Bucks, & More Boston-Area Deals News
|
Rebecca Zacks |
11/10/08 |
|
Boston
|
|
Atlas Venture Raising Half a Billion
|
Wade Roush |
11/05/08 |
|
Boston
|
|
Brightcove Bonds With AOL, Faces Competition With Akamai; Fidelity Backs EnVivo; Dyax to Sell Up To $50M in Stock; & More Boston-Area Deals News
|
Rebecca Zacks |
11/03/08 |
|
Boston
|
|
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/29/08 |
|
Boston
|
|
HC Ventures Leads $28M Round for InfaCare
|
Ryan McBride |
10/28/08 |
|
Boston
|
|
Is Brown the New Green? Why Boston’s Ugly, Expensive Macallen Condos Shouldn’t Be a Model For Green Buildings
|
Wade Roush |
10/17/08 |
|
National
|
|
Takeda Hands $20M Over to Alnylam, Skyhook Helps Mozilla Find its Way, Nuance Nabs Nokia Agreement, & More Boston-Area Deals News
|
Rebecca Zacks |
10/14/08 |
|
Boston
|
|
Atlas Leads €10M Round for Inspirational Stores
|
Wade Roush |
10/06/08 |
|
Boston
|
|
GE Shoots $4M Investment to Advanced Electron Beams
|
Ryan McBride |
09/16/08 |
|
Boston
|
|
Alnylam Adds Another RNA Approach, Vertex Tackles Hardest Hep C Cases, Zafgen Places Big Bet on Fat Shrinkers, & More Life Sciences News
|
Rebecca Zacks |
09/10/08 |
|
Boston
|
|
Zafgen, Developer of Fat-Shrinking Drugs, Hires Novartis Scientist as New CEO and Emerges From Stealth Mode
|
Luke Timmerman |
09/09/08 |
|
Boston
|
|
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News
|
Rebecca Zacks |
08/27/08 |
|
Boston
|
|
Resolvyx Pharmaceuticals Garners $4,000,000 Series B Financing
|
VentureDeal |
08/22/08 |
|
Boston
|
|
GT Solar Sees Brighter IPO Skies; Pfizer, Merck, and Eli Lilly Back Boston Startup; GSI Group Beams out $360M for Excel Technology & More Deals News
|
Rebecca Zacks |
07/14/08 |
|
Boston
|
|
The Camera is Watching You: VideoIQ Puts Smarts into Surveillance
|
Wade Roush |
07/09/08 |
|
Boston
|
|
Fear, Competition, and Greed: A Checklist for Making Your Deal Hot to VCs
|
Eric Hjerpe |
06/26/08 |
Xconomist
|
Boston
|
|
IRobot Hired to Make Shape-Shifting Robots, Alnylam Forges Asian Connection, Navic Scooped Up By Microsoft, More Orders for Evergreen Solar, & More Deals News
|
Rebecca Zacks |
06/23/08 |
|
Boston
|
|
U.S. Faces Competition in Wireless, Internet, and Biopharma, Says 2008 Venture Capital Survey (and One Local Investor)
|
Gregory T. Huang |
06/03/08 |
|
Boston
|
|
Takeda and Alnylam Join Forces, Carl Icahn Makes His Case, New England Biotech is Hot (Duh), & More Life Sciences News
|
Rebecca Zacks |
05/29/08 |
|
Boston
|
|
Evergreen Rakes in the Green, NxStage Plans Two-Stage Deal, Atlas Places Big Bet on MicroRNA, & More Deals News
|
Rebecca Zacks |
05/27/08 |
|
Boston
|
|
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen
|
Gregory T. Huang |
05/22/08 |
|
Boston
|
|
Gotuit and Lifetime Let Viewers Call the Shots
|
Erik Mellgren |
05/20/08 |
|
Boston
|
|
Mascoma Corporation Secures $61,000,000 Series C Round
|
VentureDeal |
05/06/08 |
|
Boston
|
|
Retail Convergence Meets Up With Some Cash, TheStreet Takes to Geezeo, GSK Lifts a Glass to Sirtris, & More Deals News
|
Rebecca Zacks |
04/28/08 |
|
Boston
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
|
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2008 Xconomy. All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
